RMC-035

N/A

Report date: 2024/06/27 20:00:09

Base Information

Drug NameRMC-035
Drug Alias Nameα1-microglobulin - A1M PharmaAlfa-1-Mikroglobulin - A1M PharmaAlpha-1-microglobulin - A1M PharmaROSgardRMC-035 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHemoglobins inhibitorsFree radicals scavengers
TargetsFree radicalsHemoglobins
Therapy Area/IndicationsPostoperative ComplicationsAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesA1m Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesGuard Therapeutics International AB
Inactive CompaniesN/A
Active IndicationsPostoperative Complications
Inactive IndicationsAcute Kidney Injury

Other Information

ATC CodeN/A
Related LinksN/A